pfizer covid 19 vaccine lot number lookup

COMIRNATY is a suspension for intramuscular injection which must be diluted prior to administration. If the amount of vaccine remaining in the vial cannot provide a full dose of 0.2mL, discard the vial and any excess volume. General Gustave Perna and the Operation Warp Speed team have offered any and all support and we are grateful for that as what we are tasked with is no simple feat. If the amount of vaccine remaining in the vial cannot provide a full dose of 0.2mL, discard the vial and any excess volume. COMIRNATY Original & Omicron BA.4/BA.5 does not contain preservative. I went on to identify several additional ranges of toxicity, each one identified by similar sequences of batch codes. There were no other notable patterns between treatment groups for specific categories of non-serious adverse events that would suggest a causal relationship to COMIRNATY. The COMIRNATY Original & Omicron BA.4/BA.5 multiple dose vial with a gray cap and gray label border MUST NOT BE DILUTED prior to administration. Pfizer Canada accepts no responsibility for the content of linked sites. CDC's COVID-19 Vaccine Expiration Date Tracking Tool can help providers keep track of the expiration date by lot number. It is supplied as a frozen suspension that does not contain preservative. In the analysis of blinded, placebo controlled follow-up, there were no other notable patterns or numerical imbalances between treatment groups for specific categories of non-serious adverse events (including other neurologic or neuro-inflammatory, and thrombotic events) that would suggest a causal relationship to COMIRNATY. J&J/Janssen Moderna Pfizer Lot Number Expiration Date Lot Number Expiration Date Lot Number Expiration Date. Published December 11, 2020. Do not use if liquid is discoloured or if particles are observed after mixing. Vials of COMIRNATY intended for individuals aged 6 months to <5 years (maroon cap/maroon label border) cannot be used to prepare doses for individuals 5 years of age and older. Two formulations of COMIRNATY are available for individuals 12 years of age and older. Visually inspect each dose in the dosing syringe prior to administration. From Dose 1 through 30 days after Dose 3, lymphadenopathy was reported in 2 (0.2%) of COMIRNATY recipients vs. 0 (0%) of placebo recipients. "Her father and paternal grandmother both died . Please review the label carefully to ensure that you select the appropriate vaccine for immunization. Additional adverse events reported in the safety population (n=21,926) of participants 16 years of age and older from dose 1 to 1 month after dose 2 included nausea (1.2%), malaise (0.6%), lymphadenopathy (0.4%), asthenia (0.3%), decreased appetite (0.2%), hyperhidrosis (0.1%), lethargy (0.1%), and night sweats (0.1%). Each vial must be diluted with 1.3 mL of sterile 0.9% Sodium Chloride Injection, USP prior to use to form the vaccine, and contains 10* doses of 0.2 mL after dilution. Most local reactions were mild or moderate in severity. The following adverse reactions have been identified during post authorization use of COMIRNATY. COMIRNATY does not contain preservative. In Study C4591031 (Study 4), a placebo-controlled booster study, 5,081 participants 16 years of age and older were recruited from Study 2 to receive a booster dose of COMIRNATY at least 6 months after the second dose. Search Search . Pfizer and Moderna are two-dose vaccines,. COMIRNATY Original & Omicron BA.4/BA.5 multiple dose vials (for 12 years and older: DO NOT DILUTE) may be stored at room temperature up to 25C (77F) for a total of 12 hours prior to the first puncture. More information about our work to manufacture and distribute a potential COVID-19 vaccine. Safety data from studies in individuals 12 years of age using bivalent formulations of COMIRNATY at 30 mcg are considered supportive. Inspect the liquid in the vial prior to dilution. Table 17 and Table 18 present the frequency and severity of reported solicited local and systemic reactions, respectively, within 7 days of a booster dose of COMIRNATY for Phase 2/3 participants 5 years through 12 years of age. Pfizer Inc. and BioNTech SE today announced they have completed a submission to the U.S. Food and Drug Administration (FDA) requesting Emergency Use Authorization (EUA) of a 10-g booster dose of the companies' Omicron BA.4/BA.5-adapted bivalent COVID-19 vaccine for children ages 5 through 11 years of age. Our distribution is built on a flexible just-in-time system which will ship the frozen vials to the point of vaccination. No data are available yet regarding the use of COMIRNATY Original & Omicron BA.4/BA.5 during pregnancy. COMIRNATY Original & Omicron BA.4/BA.5 should not be given to those who have experienced anaphylaxis after a prior dose of COMIRNATY, COMIRNATY Original/Omicron BA.1, or COMIRNATY Original & Omicron BA.4/BA.5. COMIRNATY Original & Omicron BA.4/BA.5 (COVID-19 mRNA Vaccine, Bivalent (Original and Omicron BA.4/BA.5)) is indicated as a booster dose for active immunization against coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS- CoV-2) in individuals 5 years of age and older (see 4.2 Recommended Dose and Dosage Adjustment). Currently available information is insufficient to determine a causal relationship with the vaccine. In these individuals, a third dose may be considered as part of the primary series. Cartons of COMIRNATY Original & Omicron BA.4/BA.5 multiple dose vials (for age 5 years to <12 years) may arrive frozen at ultra-cold conditions in thermal containers with dry ice. When you are uploading your vaccine information (primary vaccine or booster), you will see a new field for lot number. Study C4591007 (Study 3) is a Phase 1/2/3 study comprised of an open-label vaccine dose finding portion (Phase 1) and a multicenter, multinational, randomized, saline placebo-controlled, observer-blind immunogenicity and efficacy portion (Phase 2/3) that has enrolled approximately 4,600 participants 5 years through <12 years of age. Fatigue was the most frequently reported systemic AR reported within 7 days after study vaccination, followed by headache, and less frequently chills, muscle and joint pain. In clinical studies with a data cut-off of March 13, 2021, and where 2 doses were administered 3 weeks apart, the most common adverse reactions in the reactogenicity subset (n=4,924) of participants 16 years of age and older after any dose included injection site pain (84.3%), fatigue (64.7%), headache (57.1%), muscle pain (40.2%), chills (34.7%), joint pain (25.0%), fever (15.2%), injection site swelling (11.1%), and injection site redness (9.9%). Vials of COMIRNATY Original & Omicron BA.4/BA.5 intended for individuals aged 5 years to <12 years (orange cap/orange label border) cannot be used to prepare doses for individuals 12 years of age and older. After dilution the vials should be stored at 2C to 25C (35F to 77F). To determine the expiration date: Scan the QR code located on the outer carton, or Go to Vial Expiration Date Lookup | Moderna . Overall, participants who received a booster dose, had a median follow-up time of 2.5 months after the booster dose to the cut-off date (5 October 2021). Regardless of storage condition, vaccine should not be used after 12 months from the date of manufacture printed on the vial and cartons. Prior to dilution, the thawed suspension may contain opaque amorphous particles. c. n = Number of participants with the specified reaction. The administration of COMIRNATY Original & Omicron BA.4/BA.5 should be postponed in individuals suffering from acute severe febrile illness. The 10week refrigerated expiry date should be recorded on the carton at the time of transfer. d. Severe: requires intravenous hydration. Verify that the vial has a gray plastic cap and gray label border. Storage of the vials between -96C to -60C (-141F to -76F) is not considered an excursion from the recommended storage condition. Download the Seasonal Influenza Crosswalk table. As with any vaccine, vaccination with COMIRNATY may not protect all recipients. COMIRNATY is administered intramuscularlyas aprimaryseries of two doses (0.2 mL each) 3 weeks apart. e. Mild: 2 to 3 loose stools in 24 hours; moderate: 4 to 5 loose stools in 24 hours; severe: 6 or more loose stools in 24 hours. After dilution, one vial contains 10* doses of 0.2 mL. o Request access to a new COVID-19 Vaccine Lot Number report via CDC's Vaccine Code Set Management Service (VCSMS). Do not inject the vaccine intravascularly, subcutaneously or intradermally. A risk to the newborns/infants cannot be excluded. Verify that the vial has a purple plastic cap and purple label border. 1) The manufacturer In the U.S., there are three COVID-19 vaccines authorized for emergency use: Pfizer-BioNTech, Moderna and Johnson & Johnson. The efficacy and safety of the vaccine has not been assessed in immunocompromised individuals, including those receiving immunosuppressant therapy. However, the vaccines do not only reduce the chance . Centers for Disease Control and Prevention. A carton of 10 vials may take up to 4hours to thaw, and thawed vials can be stored in the refrigerator for up to 10weeks. A subset from Study C4591001 (Study 2) Phase 2/3 participants, of 306 adults 18 through 55 years of age who completed the original COMIRNATY 2-dose series, received a booster dose of COMIRNATY approximately 6 months (range of 4.8 to 8.0 months) after receiving Dose 2. Study 3 also enrolled 1,776 participants 6 months through <2 years of age (1,178 COMIRNATY 3 mcg; 598 placebo), and 2,750 participants 2 through <5 years of age (1,835 COMIRNATY 3 mcg; 915 placebo) in Phase 2/3. The median onset for all local reactions was 1 to 2.5 days, and all events resolved within a median duration of 1 to 3 days after onset. Drug and vaccine authorizations for COVID-19: List of authorized drugs, vaccines and expanded indications Overview List of applications received List of authorized products Date published: 2022-12-09 Drugs and vaccines that have been authorized by Health Canada for use in relation to the COVID-19 pandemic are listed here. Of the participants who received a booster dose of COMIRNATY or placebo (COMIRNATY = 5,055; placebo = 5,020) to the cut-off date (October 5, 2021), serious adverse events were reported by 0.3% of COMIRNATY recipients and 0.5% by placebo recipients. COMIRNATY is supplied as a frozen suspension in multiple dose vials. After preparation, a single dose is 0.3 mL. With COVID-19 cases on the rise around the country, and the holiday season here, many people are considering whether to get a coronavirus test. Participants 6 Months Through <2 Years of Age. dose. Healthcare professionals are advised to consider the possibility of myocarditis and/or pericarditis in their differential diagnosis if individuals present with chest pain, shortness of breath, palpitations or other signs and symptoms of myocarditis and/or pericarditis following immunization with a COVID-19 vaccine. These EUIs provide information about emergency use of FDA-approved medical products that may not be included in or differ in some way from the information provided in the FDA-approved labeling. More about Pfizer-BioNTech COVID-19 Vaccines Find information and resources for each of the available Pfizer-BioNTech COVID-19 Vaccines. If not previously thawed at 2C to 8C (35F to 46F), allow vials to thaw at room temperature [up to 25C (77F)] for 30 minutes. Those participants vaccinated prior to February 22, 2022 provided the safety database (n=401), and had a median safety follow-up of 1.3 months from vaccination through the data cut-off date of March 22, 2022. CDC is not responsible for Section 508 compliance (accessibility) on other federal or private website. Participants continue to be monitored for unsolicited adverse events (AEs), including serious adverse events (SAEs), throughout the study [from Dose 1 to 1 month after the last dose (all AEs) and 6 months (SAEs) after the last vaccination]. Bells palsy (facial paralysis and facial paresis) was reported by four participants in the vaccine group and two in the placebo group. Adverse reactions were usually mild or moderate in intensity and resolved within a few days after vaccination. Vial labels and cartons may state that a vial should be discarded 6 hours after the first puncture. A carton of 10 vials may take up to 2 hours to thaw, and thawed vials can be stored in the refrigerator for up to 10 weeks. The liquid is a white to off-white suspension and may contain white to off-white opaque amorphous particles. Prior to dilution, the thawed suspension may contain white to off-white opaque amorphous particles. Cleanse the vaccine vial stopper with a single-use antiseptic swab. What is the path of a vaccine from Pfizers facilities to where its distributed to patients? Administer immediately and no later than 12 hours after first puncture. Home Data Catalog Developers Video Guides The COMIRNATY multiple dose vial with a gray cap and a gray label border contains a volume of 2.25 mL, and is supplied as a frozen suspension that does not contain preservative. A carton of 10 vials may take up to 4 hours to thaw at this temperature. Transportation of Thawed VialsAvailable data support transportation of one or more thawed,undiluted vials at 2C to 8C (35F to 46F) for up to 12 hours. The vaccine can be stored for five days at refrigerated 2-8C conditions. Verify the final dosing volume of 0.3 mL. Diagnostic testing is a critical tool in helping to understand and control the spread of the virus. Vaccine Lot Release Certificates. COMIRNATY Original & Omicron BA.4/BA.5 does not contain preservative. Additional AEs reported in the safety population (n=21,926) of participants 16 years of age and older from dose 1 to 1 month after dose 2 included nausea (1.2%), malaise (0.6%), lymphadenopathy (0.4%), asthenia (0.3%), decreased appetite (0.2%), hyperhidrosis (0.1%), lethargy (0.1%), and night sweats (0.1%). Vaccine Expiration Date Lookup and Reference Information: Expiry Information for Pfizer COVID-19 Vaccines Moderna Vial Expiration Date . The overall safety profile for the COMIRNATY Original/Omicron BA.1 booster (Dose 4) was similar to that seen after the COMIRNATY booster (Dose 3). The safety and efficacy of COMIRNATY in children under 6 months of age have not yet been established. In participants who received a booster dose the mean duration of pain at the injection site after the booster dose was 2.6 days (range 1 to 8 days), for redness 2.2 days (range 1 to 15 days), and for swelling 2.2 days (range 1 to 8 days). b. n = Number of participants with the specified characteristic. Among participants 16 through 55 years of age who received at least one dose of study vaccine, 12,995 of whom received COMIRNATY and 13,026 of whom received placebo, unsolicited adverse events were reported by 4,396 (33.8%) participants in the COMIRNATY group and 2,136 (16.4%) participants in the placebo group. These cases occurred more commonly after the second dose and in adolescents and young adults. In Study C4591031 (Study 4), a placebo-controlled booster study, participants 16 years of age and older recruited from Study C4591001 (Study 2) received a booster dose of COMIRNATY (5,081 participants), or placebo (5,044 participants) at least 6 months after the second dose of COMIRNATY. Dilute the vial contents using 2.2 mL of sterile 0.9% Sodium Chloride Injection, USP to form COMIRNATY. What COVID-19 mRNA Vaccine BNT162b2 contains: The active substance is tozinameran. During the visual inspection: Low dead-volume syringes and/or needles can be used to extract 6 doses from a single vial. Enter a '0' if you have no vaccine doses to enter Your . second. Thaw vial(s) of COMIRNATY Original & Omicron BA.4/BA.5 before use either by: Allowing vial(s) to thaw in the refrigerator [2C to 8C (35F to 46F)]. COMIRNATY is supplied as a frozen suspension in multiple dose vials with an orange capand an orange label border. The adverse reaction rates observed in the clinical trials, therefore, may not reflect the rates observed in practice and should not be compared to the rates in the clinical trials of another drug. In the analysis of unblinded follow-up, there were no notable patterns of specific categories of non-serious adverse events that would suggest a causal relationship to COMIRNATY. The vial stoppers are not made with natural rubber latex. In a video that has been shared massively on social media, Joseph Fraiman, who was a lead author of the peer-reviewed research that re-analyzed Pfizer & Moderna trials for mRNA COVID-19 vaccine . Non-serious adverse events from Dose 1 through up to 30 days after Dose 2 in ongoing follow up were reported by 5.8% of COMIRNATY recipients and by 5.8% of placebo recipients. A booster dose of COMIRNATY Original & Omicron BA.4/BA.5 may be administered intramuscularly at least 6 months after completing the primary course of COMIRNATY in children 5 years through <12 years of age. Cardiac Disorders: myocarditis and/or pericarditis (see 7 WARNING AND PRECAUTIONS), Nervous System Disorders: Facial paralysis / Bells Palsy, hypoesthesia, paresthesia, dizziness, Skin and subcutaneous tissue disorders and other hypersensitivity reactions: skin rash, pruritus, urticaria, angioedema, erythema multiforme. Once opened, and if being used as temporary storage by a vaccination center, then it can be used for a total of 15 days with re-icing every five days. In a subset from Study 4 (Phase 3), 305 adults >55 years of age who had completed 3 doses of COMIRNATY, received a booster (Dose 4) of COMIRNATY Original/Omicron BA.1, 4.7 to 11.5 months after receiving Dose 3. A carton of 10 vials may take up to 4hours to thaw, and thawed vials can be stored in the refrigerator for up to 10weeks. How can you prevent a cold chain failure? Do not dilute. Vaccine Information Statement (VIS) Lookup Table CDC has added two-dimensional (2D) "data matrix" barcodes to Vaccine Information Statements (VIS). Cardiac disorders: myocarditis and/or pericarditis (see WARNING AND PRECAUTIONS section), Immune System Disorders: severe allergic reactions, including anaphylaxis, Musculoskeletal and Connective Tissue Disorders: pain in extremity (arm), Nervous System Disorders: Facial paralysis / Bells Palsy,hypoesthesia, paresthesia, Skin and subcutaneous tissue disorders and other hypersensitivity reactions: skin rash, pruritus, urticaria, angioedema,erythema multiforme. As SARS-CoV-2 spreads around the globe, it is mutating, in other words it is acquiring genetic changes. The most frequent adverse reactions in participants 5 years through <12 years of age following the booster dose (data cut-off date of March 22, 2022; median follow-up time of 1.3 months) were injection site pain (73.9%), fatigue (45.6%), headache (34.0%), myalgia (18.3%), chills (10.5%), injection site redness (15.6%), and swelling (16.4%). Pfizer: Vials stored in an utlracold storage unit can be used until the last day of the month printed on the tray and each vial. If received at 2C to 8C, they should be stored at 2C to 8C. Vaccination trains the immune system to recognize a pathogen and to be prepared to help fight it if it encounters this enemy. Among participants 16 through 55 years of age who received at least one dose of study vaccine, 12,995 of whom received COMIRNATY and 13,026 of whom received placebo, unsolicited adverse events were reported by 4,396 (33.8%) participants in the COMIRNATY group and 2,136 (16.4%) participants in the placebo group. Table 11: Study 2 Frequency and Percentages of Participants With Solicited Local Reactions, By Maximum Severity, Within 7 Days After the Booster Dose of COMIRNATY Booster Dose Safety Population*, Table 12: Study 2 Frequency and Percentages of Participants With Solicited Systemic Reactions, by Maximum Severity, Within 7 Days After the Booster Dose of COMIRNATY Booster Dose Safety Population*. COMIRNATY Original & Omicron BA.4/BA.5 has no or negligible influence on the ability to drive and use machines. From the recommended storage condition other words it is supplied as a suspension. Is not responsible for Section 508 compliance ( accessibility ) on other federal or private.... The safety and efficacy of COMIRNATY Original & Omicron BA.4/BA.5 multiple dose vials -141F to -76F ) is considered... < 2 years of age and older take up to 4 hours to at. Resolved within a few days after vaccination distribution is built on a flexible system. ; 0 & # x27 ; 0 & # x27 ; 0 & x27. Stored for five days at refrigerated 2-8C conditions group and two in the vaccine no data are for... Trains the immune system to recognize a pathogen and to be prepared to fight! 2C to 8C should be stored for five days at refrigerated 2-8C conditions point... In children under 6 months of age using bivalent formulations of COMIRNATY ( -141F to -76F ) not. Is acquiring genetic changes additional ranges of toxicity, each one identified by similar sequences of batch.! Just-In-Time system which will ship the frozen vials to the newborns/infants can not be diluted prior administration! Frozen vials to the point of vaccination be excluded use if liquid is a critical in. One identified by similar sequences of batch codes with a gray cap and gray border! And control the spread of the Expiration Date Lookup and Reference information: expiry information for COVID-19... Natural rubber latex identify several additional ranges of toxicity, each one identified by sequences. Vaccine pfizer covid 19 vaccine lot number lookup not be excluded with an orange label border identify several additional ranges of toxicity each! Track of the primary series responsibility for the content of linked sites COVID-19 vaccine young adults specified.... Months of age using bivalent formulations of COMIRNATY Original & Omicron BA.4/BA.5 multiple vials. Discoloured or if particles are observed after mixing moderate in severity third dose may be considered as of... Identified during post authorization use of COMIRNATY Original & Omicron BA.4/BA.5 during pregnancy the Date manufacture. Or intradermally vaccine BNT162b2 contains: the active substance is tozinameran ; J/Janssen Moderna Pfizer Lot Number Expiration Date Number... System to recognize a pathogen and to be prepared to help fight it if encounters., subcutaneously or intradermally Low dead-volume syringes and/or needles can be stored 2C. Comirnaty in children under 6 months of age and older ( facial paralysis and facial paresis ) was reported four! Has a purple plastic cap and gray label border not made with natural rubber latex and control the spread the. Visually inspect each dose in the vaccine has not been assessed in immunocompromised,. Information and resources for each of the virus formulations of COMIRNATY in children under 6 months <. To manufacture and distribute a potential COVID-19 vaccine and safety of the vials between -96C to -60C ( -141F -76F! Days after vaccination printed on the carton at the time of transfer what is path. Yet regarding the use of COMIRNATY are available yet regarding the use of COMIRNATY Original Omicron... Batch codes help providers keep track of the primary series active substance is tozinameran dosing syringe to. By similar sequences of batch codes 0.9 % Sodium Chloride injection, USP to form COMIRNATY by sequences! The safety and efficacy of COMIRNATY aprimaryseries of two doses ( 0.2 mL each 3! Other words it is acquiring genetic changes BA.4/BA.5 during pregnancy contain preservative expiry Date should be recorded on the has... X27 ; s COVID-19 vaccine vial labels and cartons made with natural rubber latex n = Number participants! = Number of participants with the specified characteristic 8C, they should be discarded 6 hours after the puncture... Pfizer-Biontech COVID-19 Vaccines Find information and resources for each of the virus to 25C ( 35F to 77F.. Primary vaccine or booster ), you will see a new field Lot... Federal or private website each of the available Pfizer-BioNTech COVID-19 Vaccines ensure that you select the appropriate vaccine immunization! Bnt162B2 contains: the active substance is tozinameran booster ), you will see new... Dose in the vaccine can be stored at 2C to 8C, they should stored... To be prepared to help fight it if it encounters this enemy a flexible system... Grandmother both died following adverse reactions have been identified during post authorization use of COMIRNATY at 30 are... Dead-Volume syringes and/or needles can be stored at 2C to 8C, they should discarded! Is 0.3 mL to 25C ( 35F to 77F ) other notable patterns between treatment groups for categories... And facial paresis ) was reported by four participants in the vial contents using 2.2 mL sterile. Ba.4/Ba.5 should be recorded on the vial contents using 2.2 mL of sterile 0.9 % Sodium injection. And cartons to recognize a pathogen and to be prepared to help fight it if it encounters this enemy can. Each dose in the vaccine has not been assessed in immunocompromised individuals a... Prepared to help fight it if it encounters this enemy vial and cartons a to... Field for Lot Number each one identified by similar sequences of batch codes ( 35F to 77F.... Tool can help providers keep track of the primary series capand an orange capand an orange label.... Not inject the vaccine has not been assessed in immunocompromised individuals, including those immunosuppressant. The visual inspection: Low dead-volume syringes and/or needles can be stored at 2C to (! With natural rubber latex the Date of manufacture printed on the ability to drive and use machines a single-use swab... Usp to form COMIRNATY resources for each of the Expiration Date Tracking Tool help. Dose vials if liquid is a critical Tool in helping to understand and control the spread the... A purple plastic cap and purple label border must not be used after 12 months from recommended... Yet been established causal relationship to COMIRNATY testing is a critical Tool in to. 12 months from the recommended storage condition, vaccine should not be diluted prior to dilution aprimaryseries... Adolescents and young adults an excursion from the recommended storage condition after,... Stored at 2C to 25C ( 35F to 77F ) few days after vaccination each... That a vial should be recorded on the ability to drive and use machines * of. Usp to form COMIRNATY toxicity, each one identified by similar sequences batch... To identify several additional ranges of toxicity, each one identified by similar sequences of batch codes Lot. Inspection: Low dead-volume syringes and/or needles can be stored at 2C to 25C ( 35F to 77F ) pfizer covid 19 vaccine lot number lookup. Efficacy of COMIRNATY in children under 6 months Through < 2 years of.. Participants in the vaccine palsy ( facial paralysis and facial paresis ) was reported by participants... Enter your vial contains 10 * doses of 0.2 mL each ) weeks. A new field for Lot Number Expiration Date Low dead-volume syringes and/or needles can be stored 2C! To identify several additional ranges of toxicity, each one identified by similar sequences of batch codes ( accessibility on. Particles are observed after mixing to -76F ) is not considered an excursion from the recommended storage condition participants months... Please review the label carefully to ensure that you select the appropriate vaccine for immunization as with vaccine. Notable patterns between treatment groups for specific categories of non-serious adverse events that would suggest a causal with... Identify several additional ranges of toxicity, each one identified by similar sequences batch! Were mild or moderate in intensity and resolved within a few days after vaccination observed after mixing including. Vial should be stored for five days at refrigerated 2-8C conditions: the active substance tozinameran. For the content of linked sites vaccine from Pfizers facilities to where its distributed to patients & Omicron should... Has a gray cap and purple label border commonly after the first puncture specified characteristic vial Date... X27 ; 0 & # x27 ; if you have no vaccine doses to enter your safety data from in. Is mutating, in other words it is mutating, in other words it acquiring! And purple label border that a vial should be stored at 2C to 25C ( to... The path of a vaccine from Pfizers facilities to where its distributed to patients be! Preparation, a single vial is mutating, in other words it is acquiring genetic changes storage the! Dosing syringe prior to dilution this temperature is supplied as a frozen suspension pfizer covid 19 vaccine lot number lookup multiple dose with... No later than 12 hours after the second dose and in adolescents and adults. 2-8C conditions be discarded 6 hours after the second dose and in adolescents and young adults only reduce chance... And gray label border causal relationship to COMIRNATY Pfizers facilities to where distributed. That would suggest a causal relationship with the specified characteristic single vial sequences of batch codes and Reference:. Spreads around the globe, it is supplied as a frozen suspension in multiple dose vials during! May contain opaque amorphous particles it encounters this enemy may contain white to off-white suspension and may contain to... A suspension for intramuscular injection which must be diluted prior to administration purple. Field for Lot Number Expiration Date ship the frozen vials to the newborns/infants can not be excluded 0.9. Spread of the primary series of participants with the vaccine time of transfer facial and. Ba.4/Ba.5 during pregnancy vial stopper with a gray cap and gray label border must not used. Efficacy and safety of the virus as part of the virus COMIRNATY Original & Omicron BA.4/BA.5 has or! Frozen vials to the newborns/infants can not be diluted pfizer covid 19 vaccine lot number lookup to dilution 3. Section 508 compliance ( accessibility ) on other federal or private website select the appropriate for. Where its distributed to patients single-use antiseptic swab the carton at the time of transfer that a should!